medigraphic.com
SPANISH

Revista Cubana de Hematología, Inmunología y Hemoterapia

ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (2)

Reduced glutathione levels and cellular redox status in pediatric patients with immunodeficiencies

Riverón FG, Zúñiga RY, Torres RB, Pérez RJ, Marín PL, Camayd VI
Full text How to cite this article

Language: Spanish
References: 12
Page: 1-10
PDF size: 766.49 Kb.


Key words:

immunodeficiency, pediatric patient, reduced glutathione, redox status, GSH/GSSG, HPLC.

ABSTRACT

Introduction: Alterations in the cellular redox state have been described as causal factors in various diseases. Reduced glutathione depletion has been fundamentally associated with neurodegenerative, pulmonary, liver, cardiovascular and immunological diseases.
Objective: To determine the concentrations of reduced glutathione and the cellular redox status in pediatric patients with immunodeficiencies.
Methods: We studied 21 patients with immunodeficiencies from the immunogenetic service, aged between 1 and 8 years and as a control group, 8 children in the same age range as the patients, with normal humoral and cellular immunity studies. Patients diagnosed with immunodeficiency were divided into two groups according to the affected component of the immune response: humoral and cellular. The intraerythrocyte concentrations of oxidized and reduced glutathione were determined by means of an HPLC-UV method. To evaluate the cellular redox state, the relationship between the reduced and oxidized forms of glutathione (GSH/GSSG) was calculated.
Results: Reduced glutathione concentrations and cellular redox status were found to be decreased in both groups of patients in relation to children without immunodeficiency (p=0,031 and p=0,03; respectively). Oxidized glutathione showed no difference between the groups.
Conclusions: In patients with immunodeficiency, the cellular redox state is affected as a consequence of the decrease in reduced glutathione. This first approach offers the potential for the use of these biomarkers in the comprehensive evaluation of patients with immunodeficiency.


REFERENCES

  1. Alonso A, Candelaria B, Valdés L. Inmunodeficiencias primarias: un reto para la inmunogenética. Rev Cuba Reumatol. 2020 [acceso 23/12/2021];22(2):e828. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962020000200009&lng=es1.

  2. Macías-Abraham C. Registro cubano de inmunodeficiencias primarias. Rev Cubana Hematol Inmunol Hemoter. 2017 [acceso 23/07/2021];33(S1):Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/7912.

  3. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390(3):191-214. DOI: https://10.1515/BC.2009.0333.

  4. Dröge W, Breitkreutz R. Glutathione and immune function. ProcNutr Soc. 2000;59(4):595-600. DOI: https://10.1017/s00296651000008474.

  5. Gostner JM, Becker K, Fuchs D, Sucher R. Redox regulation of the immune response. Redox Report. 2013;18(3):88-94. DOI: https://10.1179/1351000213Y.00000000445.

  6. Simona LD, Cacho C, Leva P, Barrero J, Aguar P. Development of a HPLC-UV method for simultaneous determination of intracelullar glutathione species in human cells. J Anal Bioanal Tech. 2015;6(4):259.

  7. Polonikov A. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infectious Diseases. 2020;6(7):1558-15-62. DOI: https://doi.org/10.1021/acsinfecdis.0c002887.

  8. Ghezzi P, Lemley KV, Andrus JP, De Rosa SC, Holmgren A, Jones DP, Jahoor F, et al. Cysteine/Glutathione Deficiency: A Significant and Treatable Corollary of Disease. In: Frye R., Berk M. (eds). The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine. Singapore: Adis; 2019. DOI: https://doi.org/10.1007/978-981-10-5311-5_208.

  9. Tomé D. Amino acid metabolism and signallingpatways potential target in the control of infección and inmunity. Eur J Clin Nutr 2021;75:1319-27. DOI: https://doi.org/10.1038/s41430-021-00943-09.

  10. Peng L, Yu-Long Y, Defa L, Sung WK, Guogao W. Amino acids and inmune function. Br J Nutr 2007;98(2):237-52. DOI: https://doi.org/10.1017/S000711450769936X10.

  11. Alkazemi D, Rahman A, Habra B. Alterations in glutathione redox homeostasis among adolescents with obesity and anemia. Sci Rep 2021;11:3034. DOI: https://doi.org/10.1038/s41598-021-82579-511.

  12. Kesarwani P, Murali AK, Al-Khami AA, Mehrotra S. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal. 2013;18(12):1497-1534. DOI: https://10.1089/ars.2011.4012.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Hematol Inmunol Hemoter . 2022;38